Loading clinical trials...

Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT00506142

Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma

Marqibo (liposomal vincristine) is a form of vincristine preparation. Vincristine is designed to interfere with the multiplication of cancer cells, which may slow or stop their growing and spreading t...

Lead sponsor: Spectrum Pharmaceuticals, Inc•4 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment54

Start dateNov 2007

Last updatedDec 11, 2019

Condition

Metastatic Malignant Uveal Melanoma

Locations shown

University of California, Los Angeles

Los Angeles, California

University of Colorado, Denver

Denver, Colorado

Thomas Jefferson University

Philadelphia, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 11, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions